
Gongwin Taiwan signs licensing deals to expand lung cancer drug markets
Taipei, July 16 (CNA) Biopharmaceutical company Gongwin Taiwan signed two key licensing agreements Wednesday to expand access to its innovative lung cancer drug PTS-302 in Taiwan and Malaysia, according to its parent company Gongwin Biopharm Co. (GBC). The …